Search
Allogene Therapeutics Inc
ALLOAdd to Watchlist
1.995USD
+0.035+1.79%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
488.41MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Pfizer Inc
6.39%
TPG Capital, L.P.
5.42%
Frazier Life Sciences Management, L.P.
4.70%
Citadel Advisors LLC
3.51%
BlackRock Institutional Trust Company, N.A.
3.32%
Other
76.66%
Shareholders
Shareholders
Proportion
Pfizer Inc
6.39%
TPG Capital, L.P.
5.42%
Frazier Life Sciences Management, L.P.
4.70%
Citadel Advisors LLC
3.51%
BlackRock Institutional Trust Company, N.A.
3.32%
Other
76.66%
Shareholder Types
Shareholders
Proportion
Investment Advisor
16.18%
Private Equity
12.41%
Hedge Fund
8.61%
Investment Advisor/Hedge Fund
7.80%
Corporation
6.39%
Individual Investor
4.67%
Research Firm
2.06%
Venture Capital
0.66%
Family Office
0.13%
Other
41.10%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
376
152.15M
44.66%
-33.74M
2025Q4
373
141.70M
82.47%
+102.89K
2025Q3
399
141.90M
86.43%
-23.30M
2025Q2
398
162.31M
93.64%
-14.10M
2025Q1
416
176.74M
92.40%
-25.25M
2024Q4
410
168.35M
94.70%
-249.19K
2024Q3
421
168.58M
93.61%
-350.08K
2024Q2
427
169.46M
77.53%
+34.30M
2024Q1
428
135.12M
90.51%
-19.16M
2023Q4
437
125.49M
95.40%
-8.43M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Pfizer Inc
22.03M
9.04%
--
--
Dec 31, 2025
TPG Capital, L.P.
18.72M
7.68%
--
--
Dec 31, 2025
Frazier Life Sciences Management, L.P.
3.87M
1.59%
--
--
Dec 31, 2025
Citadel Advisors LLC
12.11M
4.97%
-1.86M
-13.31%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
11.46M
4.7%
+313.30K
+2.81%
Dec 31, 2025
PRIMECAP Management Company
8.14M
3.34%
+1.06M
+14.98%
Dec 31, 2025
Belldegrun (Arie S)
7.56M
3.1%
--
--
Dec 31, 2025
Two Sigma Investments, LP
6.33M
2.59%
+137.50K
+2.22%
Dec 31, 2025
Chang (David D)
5.58M
2.29%
-47.76K
-0.85%
Mar 16, 2026
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
WisdomTree BioRevolution Fund
0.7%
Virtus LifeSci Biotech Clinical Trials ETF
0.6%
Invesco NASDAQ Future Gen 200 ETF
0.59%
Global X Genomics & Biotechnology ETF
0.2%
Zacks Small/Mid Cap ETF
0.13%
iShares Health Innovation Active ETF
0.06%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco Nasdaq Biotechnology ETF
0.03%
iShares Biotechnology ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
View more
WisdomTree BioRevolution Fund
Proportion0.7%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.6%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.59%
Global X Genomics & Biotechnology ETF
Proportion0.2%
Zacks Small/Mid Cap ETF
Proportion0.13%
iShares Health Innovation Active ETF
Proportion0.06%
ProShares Ultra Nasdaq Biotechnology
Proportion0.04%
Invesco Nasdaq Biotechnology ETF
Proportion0.03%
iShares Biotechnology ETF
Proportion0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
